Novo Nordisk downgraded to Buy amid guidance cuts & competition. Explore its long-term obesity drug potential, strong ...

Key Insights The projected fair value for Hays is UK£0.69 based on 2 Stage Free Cash Flow to Equity With UK£0.62 ...

Last week, I wrote an article about why and how sometimes we need to take a step back and look deeper into the fundamental ...